• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊偏头痛残疾评估(MIDAS)问卷的信度和效度

Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire.

作者信息

Oikonomidi Theodora, Vikelis Michail, Artemiadis Artemios, Chrousos George P, Darviri Christina

机构信息

Postgraduate Course Stress Management and Health Promotion, School of Medicine, University of Athens, 4 Soranou Ephesiou Str., 11527, Athens, Greece.

Glyfada Headache Clinic, 8 Lazaraki Str., 16675, Glyfada, Greece.

出版信息

Pharmacoecon Open. 2018 Mar;2(1):77-85. doi: 10.1007/s41669-017-0034-3.

DOI:10.1007/s41669-017-0034-3
PMID:29464670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5820235/
Abstract

BACKGROUND

The Migraine Disability Assessment (MIDAS) Questionnaire is a reliable and valid instrument for migraine-related disability. Such a tool is needed to quantify migraine-related disability in the Greek population.

OBJECTIVE

This validation study aims to assess the test-retest reliability, internal consistency, item discriminant and convergent validity of the Greek translation of the MIDAS.

METHODS

Adults diagnosed with migraine completed the MIDAS Questionnaire on two occasions 3 weeks apart to assess reliability, and completed the RAND-36 to assess validity.

RESULTS

Participants (n = 152) had a median MIDAS score of 24 and mostly severe disability (58% were grade IV). The test-retest reliability analysis (N = 59) revealed excellent reliability for the total score. Internal consistency was α = 0.71 for initial and α = 0.82 for retest completion. For item discriminant validity, the correlations between each question and the total score were significant, with high correlations for questions 2-5 (range 0.67 ≤ r ≤ 0.79; p < 0.01). For convergent validity, there was significant negative correlation between the total score and all RAND-36 subscales except for 'emotional wellbeing'. The negative correlation indicates that patients with a lower degree of disability according to their MIDAS score tended to have better wellbeing. Psychometric properties are comparable with those of other published validation studies of the MIDAS and the original. Findings on question 1 show that missing work/school days may be closely related with increased affect issues.

CONCLUSION

The Greek version of the MIDAS Questionnaire has good reliability and validity. This study allowed for cross-cultural comparability of research findings.

摘要

背景

偏头痛残疾评估(MIDAS)问卷是一种用于评估偏头痛相关残疾的可靠且有效的工具。希腊人群需要这样一种工具来量化偏头痛相关残疾。

目的

本验证研究旨在评估MIDAS希腊语翻译版的重测信度、内部一致性、项目区分效度和收敛效度。

方法

被诊断为偏头痛的成年人在相隔3周的两个时间点完成MIDAS问卷以评估信度,并完成RAND-36问卷以评估效度。

结果

参与者(n = 152)的MIDAS评分中位数为24,且大多为重度残疾(58%为IV级)。重测信度分析(N = 59)显示总分具有出色的信度。初始时内部一致性α = 0.71,重测完成时α = 0.82。对于项目区分效度,每个问题与总分之间的相关性均显著,问题2 - 5的相关性较高(范围为0.67≤r≤0.79;p < 0.01)。对于收敛效度,总分与除“情绪健康”外的所有RAND-36子量表之间存在显著负相关。负相关表明,根据MIDAS评分残疾程度较低的患者往往健康状况更好。心理测量特性与其他已发表的MIDAS验证研究及原版研究相当。问题1的结果表明,缺勤/缺课天数可能与情感问题增加密切相关。

结论

MIDAS问卷希腊语版具有良好的信度和效度。本研究实现了研究结果的跨文化可比性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6546/5820235/45ebf53c7585/41669_2017_34_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6546/5820235/45ebf53c7585/41669_2017_34_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6546/5820235/45ebf53c7585/41669_2017_34_Fig1_HTML.jpg

相似文献

1
Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire.希腊偏头痛残疾评估(MIDAS)问卷的信度和效度
Pharmacoecon Open. 2018 Mar;2(1):77-85. doi: 10.1007/s41669-017-0034-3.
2
Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.日本偏头痛残疾评估(MIDAS)问卷的信度与效度
Headache. 2003 Apr;43(4):343-52. doi: 10.1046/j.1526-4610.2003.03069.x.
3
Thai-version Migraine Disability Assessment (MIDAS) questionnaire: concurrent validity, test-retest reliability, internal consistency, and factors predictive for migraine-related disability.泰语版偏头痛残疾评估(MIDAS)问卷:同时效度、重测信度、内部一致性以及偏头痛相关残疾的预测因素。
Asian Biomed (Res Rev News). 2020 Sep 20;14(4):139-150. doi: 10.1515/abm-2020-0021. eCollection 2020 Aug.
4
Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.土耳其偏头痛残疾评估(MIDAS)问卷的效度和信度。
Headache. 2004 Sep;44(8):786-93. doi: 10.1111/j.1526-4610.2004.04146.x.
5
An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.一项评估偏头痛残疾评定量表(MIDAS)评分可靠性的国际研究。
Neurology. 1999 Sep 22;53(5):988-94. doi: 10.1212/wnl.53.5.988.
6
Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).希腊偏头痛特异性生活质量问卷(MSQ 版本 2.1-GR)的有效性和可靠性。
J Patient Rep Outcomes. 2024 Jul 15;8(1):72. doi: 10.1186/s41687-024-00762-4.
7
Reliability of the migraine disability assessment score in a population-based sample of headache sufferers.偏头痛残疾评估分数在基于人群的头痛患者样本中的可靠性。
Cephalalgia. 1999 Mar;19(2):107-14; discussion 74. doi: 10.1046/j.1468-2982.1999.019002107.x.
8
Reliability and validity of Hindi translation of the migraine disability assessment and headache impact test-6 questionnaires.偏头痛残疾评估和头痛影响测试-6问卷印地语翻译的信度和效度
Ann Indian Acad Neurol. 2010 Oct;13(4):276-83. doi: 10.4103/0972-2327.74201.
9
Development and initial validation of the Kiswahili version of the Migraine Disability Assessment (MIDAS-K) questionnaire.开发并初步验证斯瓦希里语版偏头痛残疾评估量表(MIDAS-K)问卷。
Headache. 2023 Jul-Aug;63(7):880-888. doi: 10.1111/head.14592. Epub 2023 Jun 27.
10
Validity, reliability and application of the taiwan version of the migraine disability assessment questionnaire.台湾版偏头痛残疾评估问卷的效度、信度及应用
J Formos Med Assoc. 2006 Jul;105(7):563-8. doi: 10.1016/S0929-6646(09)60151-0.

引用本文的文献

1
Effects of Pausing and Re-Initiating Fremanezumab After Continuous 24-Month Treatment for Preventing Difficult-To-Treat Migraine: Prospective, Multicenter, Real-World Data From the GRASP Study Group.连续24个月使用fremanezumab治疗后暂停并重新开始用药对预防难治性偏头痛的影响:GRASP研究组的前瞻性、多中心、真实世界数据
Eur J Neurol. 2025 Aug;32(8):e70327. doi: 10.1111/ene.70327.
2
Validity and reliability of the Greek Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1-GR).希腊偏头痛特异性生活质量问卷(MSQ 版本 2.1-GR)的有效性和可靠性。
J Patient Rep Outcomes. 2024 Jul 15;8(1):72. doi: 10.1186/s41687-024-00762-4.
3

本文引用的文献

1
Validity and reliability of the Bahasa Melayu version of the Migraine Disability Assessment questionnaire.马来语版偏头痛残疾评估问卷的效度和信度
Biomed Res Int. 2014;2014:435856. doi: 10.1155/2014/435856. Epub 2014 Jul 9.
2
Reliability and validity of the migraine disability assessment scale among migraine and tension type headache in Iranian patients.偏头痛残疾评估量表在伊朗偏头痛和紧张型头痛患者中的信度和效度
Biomed Res Int. 2014;2014:978064. doi: 10.1155/2014/978064. Epub 2014 Jan 16.
3
Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
The correlation between the frequent intake of dietary migraine triggers and increased clinical features of migraine (analytical cross-sectional study from Egypt).
饮食性偏头痛诱因的频繁摄入与偏头痛临床特征增加之间的相关性(来自埃及的分析性横断面研究)。
Sci Rep. 2024 Feb 20;14(1):4150. doi: 10.1038/s41598-024-54339-8.
4
Thai-version Migraine Disability Assessment (MIDAS) questionnaire: concurrent validity, test-retest reliability, internal consistency, and factors predictive for migraine-related disability.泰语版偏头痛残疾评估(MIDAS)问卷:同时效度、重测信度、内部一致性以及偏头痛相关残疾的预测因素。
Asian Biomed (Res Rev News). 2020 Sep 20;14(4):139-150. doi: 10.1515/abm-2020-0021. eCollection 2020 Aug.
5
Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment.偏头痛致残评估量表(修订版)葡萄牙语版的信度和效度。
BMC Neurol. 2021 Feb 6;21(1):58. doi: 10.1186/s12883-021-02085-z.
6
Validation of the Spanish version of the migraine disability assessment questionnaire (MIDAS) in university students with migraine.偏头痛残疾评估问卷(MIDAS)西班牙语版在偏头痛大学生中的验证。
BMC Neurol. 2020 Feb 24;20(1):67. doi: 10.1186/s12883-020-01646-y.
7
Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.评估非药物干预在频繁发作性或慢性偏头痛中有效性的结局指标:一项德尔菲研究。
BMJ Open. 2020 Feb 12;10(2):e029855. doi: 10.1136/bmjopen-2019-029855.
8
Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.希腊头痛学会关于偏头痛诊断和治疗的共识。
J Headache Pain. 2019 Dec 13;20(1):113. doi: 10.1186/s10194-019-1060-6.
偏头痛、可能的偏头痛和其他严重头痛的患病率、症状和相关特征的性别差异:美国偏头痛患病率和预防(AMPP)研究的结果。
Headache. 2013 Sep;53(8):1278-99. doi: 10.1111/head.12150. Epub 2013 Jun 28.
4
The International Classification of Headache Disorders, 3rd edition (beta version).《国际头痛疾病分类》第三版(试用版)
Cephalalgia. 2013 Jul;33(9):629-808. doi: 10.1177/0333102413485658.
5
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.2010 年全球疾病负担研究:1990-2010 年 289 种疾病和伤害的 1160 种后遗症导致的残疾生存年数的系统分析。
Lancet. 2012 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2.
6
MIDAS and HIT-6 French translation: reliability and correlation between tests.MIDAS和HIT-6法语翻译:测试之间的可靠性和相关性。
Cephalalgia. 2008 Jan;28(1):26-34. doi: 10.1111/j.1468-2982.2007.01461.x. Epub 2007 Oct 23.
7
Validating and norming of the Greek SF-36 Health Survey.希腊SF-36健康调查的验证与标准化
Qual Life Res. 2005 Jun;14(5):1433-8. doi: 10.1007/s11136-004-6014-y.
8
Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.土耳其偏头痛残疾评估(MIDAS)问卷的效度和信度。
Headache. 2004 Sep;44(8):786-93. doi: 10.1111/j.1526-4610.2004.04146.x.
9
Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire.日本偏头痛残疾评估(MIDAS)问卷的信度与效度
Headache. 2003 Apr;43(4):343-52. doi: 10.1046/j.1526-4610.2003.03069.x.
10
Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.偏头痛残疾评估(MIDAS)评分:与头痛频率、疼痛强度及头痛症状的关系
Headache. 2003 Mar;43(3):258-65. doi: 10.1046/j.1526-4610.2003.03050.x.